Savillex Gains Through Acquisition of Optimum Processing
Deal News | Nov 07, 2024 | Thompson Street Capital Partne
Thompson Street Capital Partners (TSCP), a private equity firm from St. Louis, alongside its portfolio company Savillex, has announced the acquisition of Optimum Processing, Inc., a manufacturer of single-use bioprocessing systems. This strategic move positions Savillex as a leader in providing fluid handling, filtration, and containment solutions, particularly to pharmaceutical and biopharmaceutical sectors. Savillex President Steve Harding emphasized the strategic synergies, highlighting enhanced product offerings and engineering expertise. The acquisition enhances Savillex's presence in the San Francisco Bay Area, reinforcing its position in the global life sciences industry. Optimum Processing, founded in 1990, specializes in custom innovative single-use bioprocessing bags and systems, and will now benefit from Savillex's robust product range and support network. Financial advisory roles in the transaction were played by Falls River Group for Optimum Processing and EC M&A for Savillex, although the financial terms of the deal were not disclosed.
Sectors
- Private Equity
- Life Sciences
- Manufacturing
- Biotechnology
Geography
- United States – Thompson Street Capital Partners, Savillex, and Optimum Processing are located in the United States.
- San Francisco Bay Area – The acquisition enhances Savillex's presence in the San Francisco Bay Area, known for its life sciences and innovation industries.
Industry
- Private Equity – The article discusses a transaction led by a private equity firm, Thompson Street Capital Partners.
- Life Sciences – Optimum Processing and Savillex are involved in the manufacture of systems used in life science applications, highlighting the relevance of this industry.
- Manufacturing – Both Optimum Processing and Savillex are manufacturers of systems and products for the life sciences sector.
- Biotechnology – Optimum Processing specializes in designing and fabricating single-use bioprocessing systems, making biotechnology a relevant industry.
Financials
- Not Disclosed – The financial terms of the acquisition between Savillex and Optimum Processing were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Thompson Street Capital Partners | Private Equity Firm | Company | A private equity firm based in St. Louis, involved in the acquisition of Optimum Processing through its portfolio company, Savillex. |
| Savillex | Target Company | Company | A portfolio company of TSCP, specializing in fluid handling, filtration, and containment solutions, and the acquirer of Optimum Processing. |
| Optimum Processing, Inc. | Target Company | Company | A manufacturer of customized, single-use bioprocessing systems for life science applications, acquired by Savillex. |
| Falls River Group | Financial Advisor to Optimum Processing | Company | Provided financial advisory services to Optimum Processing during the transaction. |
| EC M&A | Financial Advisor to Savillex | Company | Provided financial advisory services to Savillex during the acquisition of Optimum Processing. |
| Steve Harding | President of Savillex | Person | President of Savillex, part of the leadership team executing the acquisition strategy. |
| Matt Scherrer | Managing Director at TSCP | Person | Provided insights into the strategic value of the acquisition for Savillex. |